| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2022 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R21AI151767 | Novel nanoparticles function as chemo- and adjunctive-therapy against experimental cerebral malaria | 000 | 2 | NIH | 10/23/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $260,000 ) |
| | 2022 | 2022 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R21AI151767 | Novel nanoparticles function as chemo- and adjunctive-therapy against experimental cerebral malaria | 000 | 2 | NIH | 12/3/2021 | $260,000 |
| | 2022 | 2019 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R21AI137877 | Exploring a new mechanism for thrombocytopenia in experimental malaria | 000 | 2 | NIH | 11/17/2021 | $0 |
| | 2022 | 2018 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R01HL130649 | Brain vascular dysfunction in cerebral malaria | 000 | 5 | NIH | 11/26/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $221,150 ) |
| | 2021 | 2021 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R21AI151767 | Novel nanoparticles function as chemo- and adjunctive-therapy against experimental cerebral malaria | 000 | 1 | NIH | 11/27/2020 | $208,500 |
| | 2021 | 2018 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R01HL130649 | Brain vascular dysfunction in cerebral malaria | 001 | 5 | NIH | 4/30/2021 | $12,650 |
|
| Issue Date FY: 2020 ( Subtotal = $97,444 ) |
| | 2020 | 2019 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R21AI137877 | Exploring a new mechanism for thrombocytopenia in experimental malaria | 000 | 2 | NIH | 1/30/2020 | $0 |
| | 2020 | 2018 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R01HL130649 | Brain vascular dysfunction in cerebral malaria | 002 | 5 | NIH | 7/20/2020 | $97,444 |
|
| Issue Date FY: 2019 ( Subtotal = $309,000 ) |
| | 2019 | 2019 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R21AI137877 | Exploring a new mechanism for thrombocytopenia in experimental malaria | 000 | 2 | NIH | 12/13/2018 | $309,000 |
|
| Issue Date FY: 2018 ( Subtotal = $257,500 ) |
| | 2018 | 2018 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R21AI137877 | Exploring a new mechanism for thrombocytopenia in experimental malaria | 000 | 1 | NIH | 1/3/2018 | $257,500 |
| | 2018 | 2015 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R01NS079873 | Microparticles, a new player in cerebral malaria pathogenesis | 000 | 4 | NIH | 10/18/2017 | $0 |
| | 2018 | 2015 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R21NS080063 | Citrulline protects against cerebral malaria by reducing metabolic encephalopathy | 000 | 2 | NIH | 11/7/2017 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2015 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 13247 CAMINITO MENDIOLA | SAN DIEGO | CA | 92130-6962 | SAN DIEGO | USA | R01NS079873 | Microparticles, a new player in cerebral malaria pathogenesis | 000 | 4 | NIH | 11/4/2016 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $0 ) |
| | 2016 | 2015 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3525 DEL MAR HEIGHTS ROAD | SAN DIEGO | CA | 92130 | SAN DIEGO | USA | R21NS080063 | Citrulline protects against cerebral malaria by reducing metabolic encephalopathy | 000 | 2 | NIH | 9/5/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $587,500 ) |
| | 2015 | 2015 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R21NS080063 | Citrulline protects against cerebral malaria by reducing metabolic encephalopathy | 000 | 2 | NIH | 4/1/2015 | $246,250 |
| | 2015 | 2015 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R01NS079873 | Microparticles, a new player in cerebral malaria pathogenesis | 000 | 4 | NIH | 7/20/2015 | $341,250 |
|
| Issue Date FY: 2014 ( Subtotal = $729,863 ) |
| | 2014 | 2014 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R03NS081527 | RBC-derived microparticles function in cerebral malaria | 000 | 2 | NIH | 7/31/2014 | $96,525 |
| | 2014 | 2014 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R01NS079873 | Microparticles, a new player in cerebral malaria pathogenesis | 000 | 3 | NIH | 5/8/2014 | $337,838 |
| | 2014 | 2014 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R21NS080063 | Citrulline protects against cerebral malaria by reducing metabolic encephalopathy | 000 | 1 | NIH | 4/21/2014 | $295,500 |
|
| Issue Date FY: 2013 ( Subtotal = $426,806 ) |
| | 2013 | 2013 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R01NS079873 | Microparticles, a new player in cerebral malaria pathogenesis | 000 | 2 | NIH | 5/27/2013 | $329,306 |
| | 2013 | 2013 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R03NS081527 | RBC-derived microparticles function in cerebral malaria | 000 | 1 | NIH | 5/13/2013 | $97,500 |
|
| Issue Date FY: 2012 ( Subtotal = $341,250 ) |
| | 2012 | 2012 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R01NS079873 | Microparticles, a new player in cerebral malaria pathogenesis | 000 | 1 | NIH | 6/4/2012 | $341,250 |
|
| Issue Date FY: 2011 ( Subtotal = $389,025 ) |
| | 2011 | 2011 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R21NS066401 | CITRULLINE ADJUNCTIVE THERAPY FOR CEREBRAL MALARIA | 001 | 2 | NIH | 6/6/2011 | $29,250 |
| | 2011 | 2011 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R21NS066401 | CITRULLINE ADJUNCTIVE THERAPY FOR CEREBRAL MALARIA | 000 | 2 | NIH | 2/21/2011 | $263,250 |
| | 2011 | 2011 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R03AI088283 | ROLE OF PLATELET CD40 IN EXPERIMENTAL CEREBRAL MALARIA COAGULOPATHY | 000 | 2 | NIH | 2/7/2011 | $87,750 |
| | 2011 | 2011 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R03AI088283 | ROLE OF PLATELET CD40 IN EXPERIMENTAL CEREBRAL MALARIA COAGULOPATHY | 001 | 2 | NIH | 6/10/2011 | $8,775 |
|
| Issue Date FY: 2010 ( Subtotal = $341,250 ) |
| | 2010 | 2010 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R21NS066401 | CITRULLINE ADJUNCTIVE THERAPY FOR CEREBRAL MALARIA | 000 | 1 | NIH | 6/11/2010 | $243,750 |
| | 2010 | 2010 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R03AI088283 | ROLE OF PLATELET CD40 IN EXPERIMENTAL CEREBRAL MALARIA COAGULOPATHY | 001 | 1 | NIH | 7/22/2010 | $43,700 |
| | 2010 | 2010 | LA JOLLA INFECTIOUS DISEASE INSTITUTE | 3030 Bunker Hill Street | San Diego | CA | 92109-5754 | SAN DIEGO | USA | R03AI088283 | ROLE OF PLATELET CD40 IN EXPERIMENTAL CEREBRAL MALARIA COAGULOPATHY | 000 | 1 | NIH | 3/1/2010 | $53,800 |
|
|
